Clinical metagenomics for the management of hospital- and healthcare-acquired pneumonia

Future Microbiology

Volumn 11, Issue 3, 2016, Pages 427-439

  Ruppé, Etienne ^a   Baud, Damien ^a   Schicklin, Stéphane ^b   Guigon, Ghislaine ^b   Schrenzel, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b BIOMÉRIEUX   (France)

Author keywords

antibiotic resistance; diagnosis; HAP; HCAP; next generation sequencing; VAP

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; GENE SEQUENCE; GENETIC LINKAGE; GENOME; GENOTYPE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ACQUIRED PNEUMONIA; HOST PATHOGEN INTERACTION; HUMAN; METAGENOMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; BACTERIAL GENOME; BACTERIUM; BIOLOGY; CROSS INFECTION; DISEASE MANAGEMENT; DRUG EFFECTS; ENTEROBACTERIACEAE; GENETICS; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIA; COMPUTATIONAL BIOLOGY; CROSS INFECTION; DISEASE MANAGEMENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; GENOME, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; METAGENOMICS; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS;

EID: 84962425359     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.144     Document Type: Review

References (59)

1. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115(2), 462-474 (1999).
2. Piskin N, Aydemir H, Oztoprak N et al. Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes. BMC Infect. Dis. 12, 268 (2012).
3. Luna CM, Vujacich P, Niederman MS et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111(3), 676-685 (1997).
4. Bogaerts P, Hamels S, de Mendonca R et al. Analytical validation of a novel high multiplexing real-time PCR array for the identification of key pathogens causative of bacterial ventilator-associated pneumonia and their associated resistance genes. J. Antimicrob. Chemother. 68(2), 340-347 (2013).
5. Le Dorze M, Gault N, Foucrier A et al. Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia. Clin. Microbiol. Infect. 21(5), 468, e1-e6 (2014).
6. Burillo A, Rodríguez-Sánchez B, Ramiro A, Cercenado E, Rodríguez-Créixems M, Bouza E. Gram-stain plus MALDI-TOF MS (matrix-assisted laser desorption ionizationtime of flight mass spectrometry) for a rapid diagnosis of urinary tract infection. PLoS ONE 9(1), e86915 (2014).
7. Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. Matrix-assisted laser desorption ionization-time of flight mass spectrometrybased functional assay for rapid detection of resistance against β-lactam antibiotics. J. Clin. Microbiol. 50(3), 927-937 (2012).
8. Didelot X, Bowden R, Wilson DJ, Peto TEA, Crook DW. Transforming clinical microbiology with bacterial genome sequencing. Nat. Rev. Genet. 13(9), 601-612 (2012).
9. Hasman H, Saputra D, Sicheritz-Ponten T et al. Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J. Clin. Microbiol. 52(1), 139-146 (2014).
10. Al Masalma M, Lonjon M, Richet H et al. Metagenomic analysis of brain abscesses identifies specific bacterial associations. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 54(2), 202-210 (2012).
11. Arena F, Rolfe PA, Doran G et al. Rapid resistome fingerprinting and clonal lineage profiling of carbapenem-resistant Klebsiella pneumoniae isolates by targeted nextgeneration sequencing. J. Clin. Microbiol. 52(3), 987-990 (2014).
12. Lim YW, Evangelista JS, Schmieder R et al. Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis. J. Clin. Microbiol. 52(2), 425-437 (2014).
13. Stoesser N, Batty EM, Eyre DW et al. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J. Antimicrob. Chemother. 68(10), 2234-2244 (2013).
14. Köser CU, Bryant JM, Becq J et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N. Engl. J. Med. 369(3), 290-292 (2013).
15. Tyson GH, McDermott PF, Li C et al. WGS accurately predicts antimicrobial resistance in Escherichia coli. J. Antimicrob. Chemother. 70(10), 2763-2769 (2015).
16. Reuter S, Ellington MJ, Cartwright EJP et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern. Med. 173(15), 1397-1404 (2013).
17. Reuter S, Harrison TG, Köser CU et al. A pilot study of rapid whole-genome sequencing for the investigation of a Legionella outbreak. BMJ Open 3(1), e002175 (2013).
18. Török ME, Reuter S, Bryant J et al. Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak. J. Clin. Microbiol. 51(2), 611-614 (2013).
19. Köser CU, Holden MTG, Ellington MJ et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N. Engl. J. Med. 366(24), 2267-2275 (2012).
20. Stoesser N, Sheppard AE, Shakya M et al. Dynamics of MDR Enterobacter cloacae outbreaks in a neonatal unit in Nepal: insights using wider sampling frames and next-generation sequencing. J. Antimicrob. Chemother. 70(4), 1008-1015 (2015).
21. Stoesser N, Giess A, Batty EM et al. Genome sequencing of an extended series of NDMproducing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting. Antimicrob. Agents Chemother. 58(12), 7347-7357 (2014).
22. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171(4), 388-416 (2005).
23. Ruppé E, Andremont A. Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria. Front. Microbiol. 4, 129 (2013).
24. Armand-Lefèvre L, Angebault C, Barbier F et al. Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob. Agents Chemother. 57(3), 1488-1495 (2013).
25. Donskey CJ, Chowdhry TK, Hecker MT et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343(26), 1925-1932 (2000).
26. Weiss E, Zahar J-R, Lesprit P et al. Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams. Clin. Microbiol. Infect. 21(7), 649, e1-e10 (2015).
27. Jones RN. Microbial etiologies of hospitalacquired bacterial pneumonia and ventilatorassociated bacterial pneumonia. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 51(Suppl. 1), S81-S87 (2010).
28. Quartin AA, Scerpella EG, Puttagunta S, Kett DH. A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect. Dis. 13, 561 (2013).
29. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128(6), 3854-3862 (2005).
30. Chung DR, Song J-H, Kim SH et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am. J. Respir. Crit. Care Med. 184(12), 1409-1417 (2011).
31. Réseau REA-RAISIN. Surveillance des infections nosocomiales en réanimation adulte. Réseau REA-Raisin, France (2014).
32. Forel J-M, Voillet F, Pulina D et al. Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy. Crit. Care Lond. Engl. 16(2), R65 (2012).
33. Ferrer M, Liapikou A, Valencia M et al. Validation of the American Thoracic Society - Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 50(7), 945-952 (2010).
34. Falagas ME, Rafailidis PI. When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach. Shock Augusta Ga. 27(6), 605-609 (2007).
35. Martínez JL, Coque TM, Baquero F. What is a resistance gene? Ranking risk in resistomes. Nat. Rev. Microbiol. 13(2), 116-123 (2015).
36. Wright GD. The antibiotic resistome. Expert Opin. Drug Discov. 5(8), 779-788 (2010).
37. Sommer MOA, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325(5944), 1128-1131 (2009).
38. Forslund K, Sunagawa S, Kultima JR et al. Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 23(7), 1163-1169 (2013).
39. Ghosh TS, Gupta SS, Nair GB, Mande SS. In silico analysis of antibiotic resistance genes in the gut microflora of individuals from diverse geographies and age-groups. PLoS ONE 8(12), e83823 (2013).
40. Moore AM, Patel S, Forsberg KJ et al. Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS ONE 8(11), e78822 (2013).
41. Hu Y, Yang X, Qin J et al. Metagenomewide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 4, 2151 (2013).
42. Riesenfeld CS, Schloss PD, Handelsman J. Metagenomics: genomic analysis of microbial communities. Annu. Rev. Genet. 38, 525-552 (2004).
43. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18(5), 821-829 (2008).
44. Luo R, Liu B, Xie Y et al. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. GigaScience 1(1), 18 (2012).
45. Namiki T, Hachiya T, Tanaka H, Sakakibara Y. MetaVelvet: an extension of Velvet assembler to de novo metagenome assembly from short sequence reads. Nucleic Acids Res. 40(20), e155 (2012).
46. Lai B, Ding R, Li Y, Duan L, Zhu H. A de novo metagenomic assembly program for shotgun DNA reads. Bioinforma. Oxf. Engl. 28(11), 1455-1462 (2012).
47. Jain M, Fiddes IT, Miga KH, Olsen HE, Paten B, Akeson M. Improved data analysis for the MinION nanopore sequencer. Nat. Methods. 12(4), 351-356 (2015).
48. Eid J, Fehr A, Gray J et al. Real-time DNA sequencing from single polymerase molecules. Science 323(5910), 133-138 (2009).
49. Naccache SN, Federman S, Veeraraghavan N et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 24(7), 1180-1192 (2014).
50. Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 15(3), R46 (2014).
51. Burton JN, Liachko I, Dunham MJ, Shendure J. Species-level deconvolution of metagenome assemblies with Hi-C-based contact probability maps. G3 Bethesda Md 4(7), 1339-1346 (2014).
52. McArthur AG, Waglechner N, Nizam F et al. The comprehensive antibiotic resistance database. Antimicrob. Agents Chemother. 57(7), 3348-3357 (2013).
53. Zankari E, Hasman H, Cosentino S et al. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67(11), 2640-2644 (2012).
54. Gupta SK, Padmanabhan BR, Diene SM et al. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob. Agents Chemother. 58(1), 212-220 (2014).
55. Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinforma. Oxf. Engl. 22(13), 1658-1659 (2006).
56. Sirot D. Extended-spectrum plasmidmediated beta-lactamases. J. Antimicrob. Chemother. 36(Suppl. A), 19-34 (1995).
57. Kaneko K, Okamoto R, Nakano R, Kawakami S, Inoue M. Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae. J. Clin. Microbiol. 43(6), 2955-2958 (2005).
58. Gordon NC, Price JR, Cole K et al. Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing. J. Clin. Microbiol. 52(4), 1182-1191 (2014).
59. Kos VN, Déraspe M, McLaughlin RE et al. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob. Agents Chemother. 59(1), 427-436 (2015).